Application

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 90217508

Filing Date: 09/28/2020

To the Commissioner for Trademarks:

MARK: LOSING MORE WITH TIME (Standard Characters, see mark)
The literal element of the mark consists of LOSING MORE WITH TIME. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Aurinia Pharmaceuticals Inc., a company organized under the laws of Canada, having an address of
      1203-4464 Markham Street
      Victoria, BC V8Z7X8
      Canada
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 041:  Promoting and raising the awareness of lupus nephritis; providing information on lupus nephritis to the public, medical professionals, and patients; organization and presentation of seminars and informational materials relating to lupus nephritis to the public, medical professionals, and patients
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Canada application number 2051866, filed 09/16/2020.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.


International Class 042:  Research and development on lupus nephritis; conducting medical, clinical and patient studies on lupus nephritis; research and development of medicinals and pharmaceuticals
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Canada application number 2051866, filed 09/16/2020.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.




The owner's/holder's proposed attorney information: Matthew R. Wilmot. Other appointed attorneys are Anne W. Glazer, Kevin S. Crosman, Randolph C. Foster, Alfredo Villanueva, Catherine P. Lake, Joshua G. Gigger. Matthew R. Wilmot of Stoel Rives LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      760 SW Ninth Avenue, Suite 3000
      Portland, Oregon 97205
      United States
      503-294-9851(phone)
      503-220-2480(fax)
      TM-PDX@STOEL.COM
The docket/reference number is 66570.
Matthew R. Wilmot submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:

Matthew R. Wilmot

PRIMARY EMAIL FOR CORRESPONDENCE: TM-PDX@STOEL.COM       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce and was in use in commerce as of the filing date of the application on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application and was used on or in connection with the goods/services in the application as of the application filing date; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce and had a bona fide intention to use the mark in commerce as of the application filing date on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /Erik Eglite/   Date: 09/24/2020
Signatory's Name: Dr. Erik Eglite
Signatory's Position: Senior Vice President, General Counsel
Payment Sale Number: 90217508
Payment Accounting Date: 09/28/2020

Serial Number: 90217508
Internet Transmission Date: Mon Sep 28 12:57:13 ET 2020
TEAS Stamp: USPTO/BAS-XXX.XX.XXX.XX-2020092812571319
3767-90217508-750d47093549a2b6a31cba52a0
68d9337714fc6dfa53e4075db24d8427fa3238-C
C-57123553-20200923185014725914